Assessment of Stress Levels in Consumers Using Ovulation Tests in Order to Conceive
Launched by SPD DEVELOPMENT COMPANY LIMITED · Mar 9, 2010
Trial Information
Current as of June 24, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Provide written informed consent to participate in the study and agree to comply with study procedures.
- • Has menstrual bleeds.
- • Seeking to become pregnant.
- • Living in UK
- Exclusion Criteria:
- • Used hormonal contraception within the last 3 months.
- • Currently undergoing fertility treatment or investigation.
- • Diagnosed as infertile following investigations.
- • Drug or alcohol dependency.
- • history of depression, anxiety or panic attacks
About Spd Development Company Limited
SPD Development Company Limited is a leading biopharmaceutical organization dedicated to advancing innovative therapies through rigorous clinical research. With a focus on developing novel treatments across various therapeutic areas, SPD Development emphasizes scientific excellence, patient safety, and regulatory compliance. By leveraging a collaborative approach, the company aims to expedite the delivery of transformative healthcare solutions while adhering to the highest standards of quality and ethics in clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bedford, Bedfordshire, United Kingdom
Patients applied
Trial Officials
Sarah Johnson, Dr
Principal Investigator
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials